Feasibility of a pharmacy-led intervention to de-implement non-guideline-concordant proton pump inhibitor use
Abstract Background Proton pump inhibitors (PPIs) are among the most prescribed medications and are often used unnecessarily. PPIs are used for the treatment of heartburn and acid-related disorders. Emerging evidence indicates that PPIs are associated with serious adverse events, such as increased r...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2021-06-01
|
| Series: | Implementation Science Communications |
| Online Access: | https://doi.org/10.1186/s43058-021-00161-6 |